These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Montalvo AL, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, Merlini L, Buratti E, De Filippi P, Dardis A, Stroppiano M, Ciana G, Pittis MG. Hum Mutat; 2006 Oct 25; 27(10):999-1006. PubMed ID: 16917947 [Abstract] [Full Text] [Related]
28. The bovine alpha-glucosidase gene: coding region, genomic structure, and mutations that cause bovine generalized glycogenosis. Dennis JA, Moran C, Healy PJ. Mamm Genome; 2000 Mar 25; 11(3):206-12. PubMed ID: 10723725 [Abstract] [Full Text] [Related]
29. Homozygosity for multiple contiguous single-nucleotide polymorphisms as an indicator of large heterozygous deletions: identification of a novel heterozygous 8-kb intragenic deletion (IVS7-19 to IVS15-17) in a patient with glycogen storage disease type II. Huie ML, Anyane-Yeboa K, Guzman E, Hirschhorn R. Am J Hum Genet; 2002 Apr 25; 70(4):1054-7. PubMed ID: 11854868 [Abstract] [Full Text] [Related]
30. Glycogenosis type II: identification and expression of three novel mutations in the acid alpha-glucosidase gene causing the infantile form of the disease. Montalvo AL, Cariati R, Deganuto M, Guerci V, Garcia R, Ciana G, Bembi B, Pittis MG. Mol Genet Metab; 2004 Mar 25; 81(3):203-8. PubMed ID: 14972326 [Abstract] [Full Text] [Related]
31. Detection of a homozygous D645E mutation of the acid alpha-glucosidase gene and glycogen deposition in tissues in a second-trimester fetus with infantile glycogen storage disease type II. Chen CP, Lin SP, Tzen CY, Tsai FJ, Hwu WL, Wang W. Prenat Diagn; 2004 Mar 25; 24(3):231-2. PubMed ID: 15057961 [No Abstract] [Full Text] [Related]
32. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease. Nilsson MI, Kroos MA, Reuser AJ, Hatcher E, Akhtar M, McCready ME, Tarnopolsky MA. Gene; 2014 Mar 01; 537(1):41-5. PubMed ID: 24384324 [Abstract] [Full Text] [Related]
34. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, Sandkuijl LA, Reuser AJ, van der Ploeg AT. Eur J Hum Genet; 1999 Sep 01; 7(6):713-6. PubMed ID: 10482961 [Abstract] [Full Text] [Related]
35. Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II. Okumiya T, Kroos MA, Vliet LV, Takeuchi H, Van der Ploeg AT, Reuser AJ. Mol Genet Metab; 2007 Jan 01; 90(1):49-57. PubMed ID: 17095274 [Abstract] [Full Text] [Related]
37. Silent exonic mutation in the acid-alpha-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing. Maimaiti M, Takahashi S, Okajima K, Suzuki N, Ohinata J, Araki A, Tanaka H, Mukai T, Fujieda K. J Hum Genet; 2009 Aug 01; 54(8):493-6. PubMed ID: 19609281 [Abstract] [Full Text] [Related]
38. Molecular genetics of late onset glycogen storage disease II in Italy. Pittis MG, Filocamo M. Acta Myol; 2007 Jul 01; 26(1):67-71. PubMed ID: 17915575 [Abstract] [Full Text] [Related]